Measures of urine concentration in maternal urine screening for Down syndrome

Prenatal Diagnosis

Volumn 18, Issue 10, 1998, Pages 1006-1009

  Iles, R K ^a   Black, A ^a   Gunn, L K ^a   Sehmi, I K ^b   Cuckle, H S ^b   Chard, T ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Creatinine; Down syndrome; hCG; Maternal urine; Screening

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CREATININE;

ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DOWN SYNDROME; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; KIDNEY CONCENTRATING CAPACITY; NORMAL HUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCREENING TEST; URINE OSMOLALITY;

CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; KIDNEY CONCENTRATING ABILITY; LINEAR MODELS; OSMOLAR CONCENTRATION; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0031794763     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(1998100)18:10<1006::AID-PD386>3.0.CO;2-O     Document Type: Article

References (15)

1. Boeniger, M.F., Lowry, L.K., Rosenberg, J. (1993). Interpretation of urine results used to assess chemical exposures with emphasis on creatinine adjustments: a review, Am. Ind. Hyg. Assoc. J., 54, 615-627.
2. Canick, J.A., Kellner, L.H., Saller, D.N., Palomaki, G.E., Walker, R.P., Osathanondh, R. (1995). Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy, Prenat. Diagn., 15, 739-744.
3. Cuckle, H., Iles, R.K., Chard, T. (1994). Urinary β-core human chorionic gonadotrophin: a new approach to Down's syndrome screening, Prenat. Diagn., 14, 953-958.
4. Cuckle, H.S., Iles, R.K., Sehmi, I.K., Chard, T., Oakey, R.E., Davies, S., Ind, T. (1995). Urinary multiple marker screening for Down's syndrome, Prenat. Diagn., 15, 745-751.
5. Cuckle, H.S., Canick, J.A., Kellner, L.H., van Lith, J.M.M., White, I., Helbig, B.R., Rose, N.C., Sehmi, I.K., Jones, R. (1996). Urinary β-core hCG screening in the first trimester, Prenat. Diagn., 16, 1057-1059.
6. Gowans, E.M., Fraser, C.G. (1988). Biological variation of serum and urine creatinine and creatinine clearance: ramifications for the interpretation of results and patient care, Ann. Clin. Biochem., 25, 259-263.
7. Isozaki, T., Palomaki, G.E., Mahoney, M.J., Bahado-Singh, R.O., Cole, L. (1997). Screening for Down Syndrome pregnancy using β-core fragment: prospective study, Prenat. Diagn., 17, 407-413.
8. Kellner, L.H., Canick, J.A., Palomaki, G.E., Neveux, L.M., Saller, D.N., Walker, R.P., Osathanondh, R., Bombard, A.T. (1997). Levels of urinary beta-core fragment, total oestriol and the ratio of the two in second-trimester screening for Down syndrome, Prenat. Diagn., 17, 1135-1141.
9. Knuppel, R.A., Sbarra, A.J., Cetrulo, C.L., Kappy, K.A., Ingaradia, C.J., Selvaraj, R.J. (1979). 24-hour urine creatinine excretion in pregnancy, Obstet. Gynaecol., 54, 327-329.
10. Korman, L.H., Morssink, L.P., Wortelboer, M.J.M., Beekhuis, J.R., de Wolf, B.T.H.M., Pratt, J.J., Mantingh, A. (1997). Maternal urinary β-core hCG in chromosomally abnormal pregnancies in the first trimester, Prenat. Diagn., 17, 135-139.
11. Lee, C.L., Iles, R.K., Shepherd, J.H., Hudson, C.N., Chard, T. (1991). The purification and development of a radioimmunoassay for β-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women, J. Endocrinol., 130, 481-489.
12. Macintosh, M.C.M., Nicoliades, K.H., Noble, P., Chard, T., Gunn, L., Iles, R. (1997). Urinary β-core-hCG: screening for aneuploidies in early prengnacy (11 to 14 weeks' gestation), Prenat. Diagn., 17, 401-405.
13. Spencer, K., Aitken, D.A., Macri, J.N., Buchanan, P.D. (1996). Urine free beta hCG and beta core in pregnancies affected by Down's syndrome, Prenat. Diagn., 16, 605-613.
14. Spencer, K., Noble, P., Snijders, R.J.M., Nicoliades, K.H. (1997). First-trimester urine free-beta hCG, beta-core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free-beta hCG, Prenat. Diagn., 17, 525-538.
15. Wehmann, R.E., Blithe, D.L., Flack, M.R., Nisula, B.C. (1989). Metabolic clearance rate and urinary clearance of purified β-core, J. Clin. Endocrinol. Metab., 69, 510-517.